Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

Clinical trial NCT00520494 · COMPLETED

Trial details

NCT number: NCT00520494
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Common Variable Immunodeficiency Agammaglobulinemia

Start date: 2007-03-01
Primary completion: 2008-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.